首页 文献索引 SCI期刊 AI助手
首页 正文

JAMA pediatrics. 2025 Jan 21. doi: 10.1001/jamapediatrics.2024.5429 Q118.02025

Montelukast Use and the Risk of Neuropsychiatric Adverse Events in Children

孟鲁司特使用与儿童神经精神不良事件风险的关系 翻译改进

Viktor Wintzell  1, Philip Brenner  2  3  4  5, Linda Halldner  6  7, Samuel Rhedin  6  8, Tong Gong  6, Catarina Almqvist  6  9

作者单位 +展开

作者单位

  • 1 Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
  • 2 Centre for Pharmacoepidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
  • 3 Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • 4 Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • 5 Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden.
  • 6 Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • 7 Department of Clinical Sciences, Child and Adolescent Psychiatry, Umea University, Umea, Sweden.
  • 8 Sachs' Children and Youth Hospital, Stockholm, Sweden.
  • 9 Pediatric Allergy and Pulmonology Unit at Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.

    • DOI: 10.1001/jamapediatrics.2024.5429 PMID: 39836401

    摘要 Ai翻译

    Importance: Spontaneous reports have indicated that montelukast increases the risk of neuropsychiatric adverse events, and the US Food and Drug Administration added a boxed warning about these risks in 2020. However, the potential mechanism is not well understood, and the observational evidence is scarce, particularly in children. Objective: ... ...点击完成人机验证后继续浏览
    Copyright © JAMA pediatrics. 中文内容为AI机器翻译，仅供参考！

    相关内容

    期刊名：Jama pediatrics

    缩写：JAMA PEDIATR

    ISSN：2168-6203

    e-ISSN：2168-6211

    IF/分区：18.0/Q1

    文章目录 更多期刊信息

    全文链接
    官方链接
    PMC全文
    引文链接
    复制
    已复制！
    推荐内容
    Montelukast Use and the Risk of Neuropsychiatric Adverse Events in Children